Clinical Trial Update: The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether short-term use of statins and NSAIDs alters beta-amyloid levels in Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nonsteroidal anti-inflammatory drugs (NSAID)
• Statins

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED